HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulation of caspase activation in axotomized retinal ganglion cells.

Abstract
Transection of the optic nerve initiates massive death of retinal ganglion cells (RGCs). Interestingly, despite the severity of the injury, RGC loss was not observed until several days after axotomy. The mechanisms responsible for this initial lack of RGC death remained unknown. In the current study, immunohistochemical analysis revealed that caspases-3 and -9 activation in the RGCs were not detected until day 3 post-axotomy, coinciding with the onset of axotomy-induced RGC loss. Interestingly, elevated Akt phosphorylation was observed in axotomized retinas during the absence of caspase activation. Inhibiting the increase in Akt phosphorylation by intravitreal injection of wortmannin and LY294002, inhibitors of PI3K, resulted in premature nuclear fragmentation, caspases-3 and -9 activation in the ganglion cell layer. Our findings thus indicate that the PI3K/Akt pathway may serve as an endogenous regulator of caspase activation in axotomized RGCs, thereby, contributing to the late onset of RGC death following axotomy.
AuthorsZelda H Cheung, Yuen-Man Chan, Flora K W Siu, Henry K Yip, Wutian Wu, Mason C P Leung, Kwok-Fai So
JournalMolecular and cellular neurosciences (Mol Cell Neurosci) Vol. 25 Issue 3 Pg. 383-93 (Mar 2004) ISSN: 1044-7431 [Print] United States
PMID15033167 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromones
  • Enzyme Inhibitors
  • Morpholines
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Caspase 3
  • Caspase 9
  • Caspases
Topics
  • Animals
  • Axotomy (methods)
  • Caspase 3
  • Caspase 9
  • Caspases (metabolism)
  • Chromones (pharmacology)
  • Cricetinae
  • Enzyme Activation (drug effects, physiology)
  • Enzyme Inhibitors (pharmacology)
  • Mesocricetus
  • Morpholines (pharmacology)
  • Optic Nerve Injuries (enzymology)
  • Retinal Ganglion Cells (drug effects, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: